Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | BLVRB | P30043 | 1/20 | 0.56 |
| ▸ | KDR | P35968 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12374379 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL26730466 | 0.88 | MEN1 (0.70) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL3385330 | 0.88 | MEN1 (0.70) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL1624756 | 0.88 | MEN1 (0.70) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL10930328 | 0.86 | MEN1 (0.68) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL3437517 | 0.82 | MEN1 (0.44) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL3386039 | 0.81 | MEN1 (0.85) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL1624852 | 0.81 | MEN1 (0.85) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL10334178 | 0.79 | KMT2A (0.59) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL10334179 | 0.79 | KMT2A (0.59) | ALDH1A1TSHRCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220142889-A1 | TOPICAL COMPOSITION | FRAMERGY INC. | 2022-05-12 | — | — | US | disclosed |
| US-20220023829-A1 | AMORPHOUS METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARING THE SAME | ABSORPTION SOLUTIONS LLC | 2022-01-27 | — | — | US | disclosed |
| US-8940392-B2 | Titanium based inorganic-organic hybrid solid material, method for preparing same and uses thereof | UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (FR) | 2015-01-27 | — | — | US | disclosed |
| US-20120121904-A1 | TITANIUM BASED INORGANIC-ORGANIC HYBRID SOLID MATERIAL, METHOD FOR PREPARING SAME AND USES THEREOF | L'UNIVERSITE PIERRE ET MARIE CURIE, (PARIS 6) (FR) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142889-A1 | TOPICAL COMPOSITION | CUTA, TYR, ERCC4 | ALDH1A1 1484/4885TSHR 3821/4885CA12 2610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.